Evidence map›Paper›PMID 31979091›Full record

ArticleDiagnostics (Basel, Switzerland)2020

Active MMP-8 (aMMP-8) as a Grading and Staging Biomarker in the Periodontitis Classification.

Timo Sorsa, Saeed Alassiri, Andreas Grigoriadis, Ismo T Räisänen, Pirjo Pärnänen, Solomon O Nwhator, Dirk-Rolf Gieselmann, Dimitra Sakellari

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06701058 (Active MMP-8 in Oral Fluid for the Detection of Oral and Oropharyngeal Cancer), which is not on this map. Cited by 108 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed, 4 pooled it
14.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06701058 completednot on this mapstarted 2022, after this paper: background citation

Active MMP-8 in Oral Fluid for the Detection of Oral and Oropharyngeal Cancer

Typeobservational_patient_registrySponsorHelsinki University Central HospitalRan2022 to 2024Enrolled107ConditionsOropharyngeal Cancers, Biomarker in Early Diagnosis, Oral Cancer , Oral Squamous Cell Carcinoma, Oral Cavity Cancer, Periodontal Diseases
3 · Its place in the literature

Who cites it

108 citing papers in PubMed, 4 syntheses or guidelines pooled it, 158 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Review
  12. Article
  13. Observational
  14. Review
  15. Article
  16. Hidden oral inflammation and biomarker misclassification in obstructive sleep apnea trials.Sleep advances : a journal of the Sleep Research Society · 2026
    Article
  17. Article
  18. Review
  19. Review
  20. Article

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 4 countries.

Timo SorsaDepartment of Oral and Maxillofacial Diseases, Head and Neck Center, University of Helsinki and Helsinki University Hospital, P.O. Box 63 (Haartmaninkatu 8) FI-00014, 00100 Helsinki, Finland.
Saeed AlassiriDepartment of Oral and Maxillofacial Diseases, Head and Neck Center, University of Helsinki and Helsinki University Hospital, P.O. Box 63 (Haartmaninkatu 8) FI-00014, 00100 Helsinki, Finland.
Andreas GrigoriadisDepartment of Preventive Dentistry, Periodontology and Implant Biology, Dental School, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Ismo T RäisänenDepartment of Oral and Maxillofacial Diseases, Head and Neck Center, University of Helsinki and Helsinki University Hospital, P.O. Box 63 (Haartmaninkatu 8) FI-00014, 00100 Helsinki, Finland.
Pirjo PärnänenDepartment of Oral and Maxillofacial Diseases, Head and Neck Center, University of Helsinki and Helsinki University Hospital, P.O. Box 63 (Haartmaninkatu 8) FI-00014, 00100 Helsinki, Finland.
Solomon O NwhatorDepartment of Preventive & Community Dentistry, Faculty of Dentistry, College of Health Sciences, Obafemi Awolowo University, Ile-Ife 220104 Osun State, Nigeria.
Dirk-Rolf GieselmannInstitute for Molecular Diagnostics (IMOD), Bonner Str. 84, 42697 Solingen, Germany.
Dimitra SakellariDepartment of Preventive Dentistry, Periodontology and Implant Biology, Dental School, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
University of Helsinki · FIAristotle University of Thessaloniki · GRObafemi Awolowo University · NG

Funding

Helsingin Seudun Hammaslääkärit r.y. N/AHelsingin Yliopiston Tiedesäätiö TYH 2016251Helsingin Yliopiston Tiedesäätiö TYH 2017251Helsingin Yliopiston Tiedesäätiö TYH 2018229Helsingin Yliopiston Tiedesäätiö TYH 2019314Helsingin Yliopiston Tiedesäätiö Y1014SL017Helsingin Yliopiston Tiedesäätiö Y1014SL018Helsingin Yliopiston Tiedesäätiö Y1014SULE1Karolinska Institutet N/AOrion Research Foundation sr N/APaulon Säätiö N/A
6 · The paper itself

Abstract

The aim of this study was to investigate the utility of incorporating active matrix metalloproteinase-8 (aMMP-8) as a biomarker into the new periodontitis classification system (stage/grade) presented in 2018. This study included 150 Greek adults aged 25-78, of whom 74 were men and 76 women. Participants were tested with an aMMP-8 point-of-care mouthrinse test, after which a full-mouth clinical examination was performed to assess their periodontal and oral health. The aMMP-8 levels in mouthrinse were significantly lower among healthy patients compared with patients in more severe periodontitis stages and grades (Kruskal-Wallis test and Dunn-Bonferroni test for pairwise post-hoc comparisons;

Indexed as

biomarkersdiagnosismatrix metalloproteinase 8molecular diagnosticsperiodontal diseasesperiodontitispoint-of-care testing

Identifiers

PMID31979091
PMCPMC7168924
OpenAlexW3000757427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.